10.1 Rate of falls |
1 |
|
Rate Ratio (IV, Fixed, 95% CI) |
Subtotals only |
10.1.1 Hormone replacement therapy vs placebo |
1 |
212 |
Rate Ratio (IV, Fixed, 95% CI) |
0.88 [0.65, 1.18] |
10.1.2 Hormone replacement therapy + calcitriol vs placebo |
1 |
214 |
Rate Ratio (IV, Fixed, 95% CI) |
0.75 [0.58, 0.97] |
10.2 Number of fallers |
3 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Subtotals only |
10.2.1 Hormone replacement therapy vs control/placebo |
2 |
585 |
Risk Ratio (IV, Fixed, 95% CI) |
0.94 [0.81, 1.08] |
10.2.2 Hormone replacement therapy + calcitriol vs placebo |
1 |
214 |
Risk Ratio (IV, Fixed, 95% CI) |
0.90 [0.72, 1.11] |
10.2.3 Alendronate + vitamin D3 vs control |
1 |
515 |
Risk Ratio (IV, Fixed, 95% CI) |
0.82 [0.59, 1.14] |
10.3 Number of people sustaining a fracture |
1 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Subtotals only |
10.3.1 Calcium vs placebo |
1 |
1255 |
Risk Ratio (IV, Fixed, 95% CI) |
0.90 [0.69, 1.16] |
10.3.2 Vitamin K2 + vitamin D2 + calcium vs control (Alzheimer's disease) |
0 |
0 |
Risk Ratio (IV, Fixed, 95% CI) |
Not estimable |